IRD insider transaction filings
Opus Genetics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-27. Screen IRD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Gagnon Robert E. — Chief Financial Officer | Sale (S): 7,783 @ $2.95 | EDGAR |
| 2026-07-27 | 4 | Magrath George — Chief Executive Officer, Director | Sale (S): 9,475 @ $2.95 | EDGAR |
| 2026-07-27 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Sale (S): 4,644 @ $2.94 | EDGAR |
| 2026-07-27 | 4 | YERXA BENJAMIN R — President, Director | Sale (S): 7,429 @ $2.97 | EDGAR |
| 2026-05-20 | 4 | Foundation Fighting Blindness Retinal Degeneration Fund — Director Foundation Fighting Blindness, Inc. — Director | Sale (S): 1,700,000 @ $4.35 | EDGAR |
| 2026-04-27 | 4 | Zaremba Rabourn Amy — Head of Fin. Quality Assurance | Sale (S): 1,641 @ $5.20 | EDGAR |
| 2026-04-27 | 4 | Magrath George — Chief Executive Officer, Director | Sale (S): 9,511 @ $5.22 | EDGAR |
| 2026-04-27 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Sale (S): 7,542 @ $5.19 | EDGAR |
| 2026-04-27 | 4 | Gagnon Robert E. — Chief Financial Officer | Sale (S): 7,842 @ $5.18 | EDGAR |
| 2026-04-27 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Sale (S): 4,697 @ $5.22 | EDGAR |
| 2026-04-27 | 4 | YERXA BENJAMIN R — President, Director | Sale (S): 7,470 @ $5.24 | EDGAR |
| 2026-04-22 | 4 | Rodgers Richard J — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | Graves Adrienne L — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | Gallagher Cam — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | Benton Susan — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | Bennett Jean — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-04-22 | 4 | Ainsworth Sean — Director | Grant/award (A): 24,367 @ $0 | EDGAR |
| 2026-03-18 | 4 | Zaremba Rabourn Amy — Head of Fin. Quality Assurance | Sale (S): 2,816 @ $5.25 | EDGAR |
| 2026-03-18 | 4 | Magrath George — Chief Executive Officer, Director | Sale (S): 24,438 @ $5.21 | EDGAR |
| 2026-03-18 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Sale (S): 3,719 @ $5.12 | EDGAR |
| 2026-03-18 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Sale (S): 3,719 @ $5.25 | EDGAR |
| 2026-02-17 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Tax withholding (F): 5,313 @ $3.39 | EDGAR |
| 2026-01-26 | 4 | Zaremba Rabourn Amy — Head of Fin. Quality Assurance | Grant/award (A): 86,500 @ $0 | EDGAR |
| 2026-01-26 | 4 | Magrath George — Chief Executive Officer, Director | Grant/award (A): 483,639 @ $0 | EDGAR |
| 2026-01-26 | 4 | Jayagopal Ashwath — Chief Scientific & Dev. Ofc. | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-01-26 | 4 | Gagnon Robert E. — Chief Financial Officer | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-01-26 | 4 | SCHACHLE JOSEPH K — Chief Operating Officer | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2026-01-26 | 4 | YERXA BENJAMIN R — President, Director | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-01-21 | 4 | Zaremba Rabourn Amy — Head of Fin. Quality Assurance | Tax withholding (F): 3,390 @ $2.10 | EDGAR |
| 2026-01-13 | 4 | Zaremba Rabourn Amy — Head of Fin. Quality Assurance | Tax withholding (F): 3,950 @ $1.93 | EDGAR |
| 2026-01-08 | 4 | Gallagher Cam — Director | Grant/award (A): 67,000 @ $0 | EDGAR |
| 2026-01-05 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 31,188 | EDGAR |
| 2026-01-05 | 4 | Graves Adrienne L — Director | Grant/award (A): 23,643 | EDGAR |
| 2026-01-05 | 4 | Bennett Jean — Director | Grant/award (A): 21,127 | EDGAR |
| 2026-01-05 | 4 | Ainsworth Sean — Director | Grant/award (A): 42,507 | EDGAR |
| 2025-12-31 | 4 | Gallagher Cam — Director | Purchase (P): 81,000 @ $1.98 · Purchase (P): 83,000 @ $1.97 · Grant/award (A): 33,000 @ $0 | EDGAR |
| 2025-12-11 | 4 | Foundation Fighting Blindness Retinal Degeneration Fund — Director Foundation Fighting Blindness, Inc. — Director | Sale (S): 4,000,000 @ $2.15 | EDGAR |
| 2025-11-05 | 4/A | Magrath George — Chief Executive Officer, Director | Tax withholding (F): 30,350 @ $2.30 | EDGAR |
| 2025-11-04 | 4 | Magrath George — Chief Executive Officer, Director | Tax withholding (F): 30,350 @ $2.30 | EDGAR |
| 2025-10-24 | 4 | YERXA BENJAMIN R — President, Director | Tax withholding (F): 23,795 @ $1.95 | EDGAR |
| 2025-09-11 | 4 | Gagnon Robert E. — Chief Financial Officer | Grant/award (A): 200,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Gallagher Cam — Director | Grant/award (A): 869,565 @ $1.15 | EDGAR |
| 2025-08-27 | 4 | Ainsworth Sean — Director | Grant/award (A): 86,956 @ $1.15 | EDGAR |
| 2025-05-06 | 4 | Foundation Fighting Blindness Retinal Degeneration Fund — Director, 10% owner Foundation Fighting Blindness, Inc. — Director, 10% owner | Conversion (C): 6,927,419 · Conversion (C): 6,927.42 (derivative) | EDGAR |
| 2025-05-02 | 4 | Rodgers Richard J — Director | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Graves Adrienne L — Director | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Gallagher Cam — Director | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Benton Susan — Director | Grant/award (A): 79,504 @ $0 · Grant/award (A): 79,592 (derivative) @ $0 | EDGAR |
Recent 8-K events — Opus Genetics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2026-04-22 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IRD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →